News

Brachytherapy and ocular melanomas. Ocular melanoma, though rare relative to all other cancers, is the most common type of eye cancer in adults. Plaque brachytherapy treatments deliver radiation to ...
ARVO 2012: Early diagnosis of radiation retinopathy after plaque brachytherapy, followed by prompt treatment with intravitreal bevacizumab, may prevent vision loss in patients with uveal melanoma.
Bowen explained that there are three different treatment options for uveal melanoma. The most common treatment method is plaque brachytherapy, which involves inserting seeds of the radioactive ...
IDEAYA said that for the enucleation cohort, the randomisation will be with or without darovasertib as neoadjuvant therapy; and for the plaque brachytherapy cohort, the randomisation will be ...
A 55-year-old white female presented to our clinics for a comprehensive eye examination. Her ocular history was significant for a choroidal nevus in the right eye and a choroidal melanoma in the ...
Plaque Brachytherapy is a sophisticated and localized radiation therapy for treatment of recurrent retinoblastoma, as it provides focused treatment of eye cancer without damaging the surrounding ...
Plaque brachytherapy: radiation therapy used to treat eye tumors. Progression-free survival: the length of time during and after treatment that a patient lives with the disease but it does not get ...
About Radiation Retinopathy. Radiation retinopathy (RR) is a common complication after Iodine-125 plaque brachytherapy for choroidal melanoma. Although the initial radiation insult is immediate ...
ATLANTA, March 19, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and ...
ATLANTA, March 19, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and ...